Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seeman

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|December 14, 2007
Glutamate agonists for schizophrenia stimulate dopamine D2High receptorsPhilip Seeman
CNS Neuroscience & Therapeutics|June 22, 2010
All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptorsPhilip Seeman
Clinical Schizophrenia & Related Psychoses|July 21, 2010
Dopamine D2 receptors as treatment targets in schizophreniaPhilip Seeman
Expert Opinion on Therapeutic Targets|July 20, 2006
Targeting the dopamine D2 receptor in schizophreniaPhilip Seeman
Science (New York, N.Y.)|July 13, 2004
Comment on "Diverse psychotomimetics act through a common signaling pathway"Philip Seeman
Synapse (New York, N.Y.)|September 17, 2008
Dopamine D2(High) receptors moderately elevated by bifeprunox and aripiprazolePhilip Seeman
The American Journal of Psychiatry|October 4, 2005
An update of fast-off dopamine D2 atypical antipsychoticsPhilip Seeman
Healthcare Quarterly (Toronto, Ont.)|August 5, 2005
Getting to the source of schizophreniaPhilip Seeman
Synapse (New York, N.Y.)|February 23, 2008
Dopamine D2(High) receptors moderately elevated by sertindolePhilip Seeman
Synapse (New York, N.Y.)|February 5, 2008
Dopamine D2(High) receptors on intact cellsPhilip Seeman
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|December 14, 2007
Glutamate agonists for schizophrenia stimulate dopamine D2High receptorsPhilip Seeman
CNS Neuroscience & Therapeutics|June 22, 2010
All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptorsPhilip Seeman
Clinical Schizophrenia & Related Psychoses|July 21, 2010
Dopamine D2 receptors as treatment targets in schizophreniaPhilip Seeman
Expert Opinion on Therapeutic Targets|July 20, 2006
Targeting the dopamine D2 receptor in schizophreniaPhilip Seeman
Science (New York, N.Y.)|July 13, 2004
Comment on "Diverse psychotomimetics act through a common signaling pathway"Philip Seeman
Synapse (New York, N.Y.)|September 17, 2008
Dopamine D2(High) receptors moderately elevated by bifeprunox and aripiprazolePhilip Seeman
The American Journal of Psychiatry|October 4, 2005
An update of fast-off dopamine D2 atypical antipsychoticsPhilip Seeman
Healthcare Quarterly (Toronto, Ont.)|August 5, 2005
Getting to the source of schizophreniaPhilip Seeman
Synapse (New York, N.Y.)|February 23, 2008
Dopamine D2(High) receptors moderately elevated by sertindolePhilip Seeman
Synapse (New York, N.Y.)|February 5, 2008
Dopamine D2(High) receptors on intact cellsPhilip Seeman
Pageof 11